GLMD vs. GOLY
GLMD (Galmed Pharmaceuticals Ltd.) is a stock, while GOLY (Strategy Shares Gold-Hedged Bond ETF) is Nontraditional Bonds fund tracking the Solactive Gold-Backed Bond Index. Over the past 5 years, GLMD returned -74.30%/yr vs 4.15%/yr for GOLY. At a 0.08 correlation, their price movements are largely independent.
Performance
GLMD vs. GOLY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with GLMD having a -28.47% return and GOLY slightly higher at -27.51%.
GLMD
- 1D
- -4.14%
- 1M
- -12.29%
- 6M
- -35.75%
- YTD
- -28.47%
- 1Y
- -72.26%
- 3Y*
- -68.64%
- 5Y*
- -74.30%
- 10Y*
- -51.79%
GOLY
- 1D
- -3.10%
- 1M
- -5.87%
- 6M
- -31.45%
- YTD
- -27.51%
- 1Y
- -11.02%
- 3Y*
- 13.08%
- 5Y*
- 4.15%
- 10Y*
- —
GLMD vs. GOLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -28.47% | -76.47% | -41.58% | -93.93% | -72.53% | -26.91% |
GOLY Strategy Shares Gold-Hedged Bond ETF | -27.51% | 57.98% | 19.82% | 12.74% | -19.96% | -1.40% |
Correlation
The correlation between GLMD and GOLY is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since May 18, 2021 | 0.08 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. GOLY — Risk / Return Rank
GLMD
GOLY
GLMD vs. GOLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Strategy Shares Gold-Hedged Bond ETF (GOLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | GOLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.44 | ||
| Sortino ratioReturn per unit of downside risk | -1.00 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 0.97 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | -0.30 | -0.61 |
| Martin ratioReturn relative to average drawdown | -1.19 | -0.65 | -0.55 |
Loading charts...
Drawdowns
GLMD vs. GOLY - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, which is greater than GOLY's maximum drawdown of -37.45%. Use the drawdown chart below to compare losses from any high point for GLMD and GOLY.
Loading charts...
Drawdown Indicators
| GLMD | GOLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -37.45% | -62.54% |
Max Drawdown (1Y)Largest decline over 1 year | -79.86% | -37.45% | -42.41% |
Max Drawdown (3Y)Largest decline over 3 years | -97.30% | -37.45% | -59.85% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -37.45% | -62.47% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | — | — |
Current DrawdownCurrent decline from peak | -99.98% | -37.45% | -62.53% |
Average DrawdownAverage peak-to-trough decline | -76.17% | -12.30% | -63.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.48% | 17.05% | +43.43% |
Volatility
GLMD vs. GOLY - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 27.61% compared to Strategy Shares Gold-Hedged Bond ETF (GOLY) at 8.43%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than GOLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | GOLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.61% | 8.43% | +19.18% |
Volatility (6M)Calculated over the trailing 6-month period | 75.30% | 30.38% | +44.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 94.28% | 34.00% | +60.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.90% | 22.70% | +144.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.26% | 22.46% | +115.80% |
Dividends
GLMD vs. GOLY - Dividend Comparison
GLMD has not paid dividends to shareholders, while GOLY's dividend yield for the trailing twelve months is around 10.15%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GOLY Strategy Shares Gold-Hedged Bond ETF | 10.15% | 7.22% | 3.85% | 2.94% | 2.57% | 1.11% |
Frequently Asked Questions
GLMD and GOLY have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (27.61%) compared to GOLY (8.43%). In terms of maximum drawdown, GLMD dropped -99.99% vs GOLY's -37.45%.
GOLY currently has the higher Sharpe Ratio (-0.33 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and GOLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer